p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 4, Issue 4, Pages e589-e589
Publisher
Springer Nature
Online
2013-04-11
DOI
10.1038/cddis.2013.118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional Sphere Profiling Reveals the Complexity of Neuroblastoma Tumor-Initiating Cell Model
- (2015) Aurélie Coulon et al. NEOPLASIA
- CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway
- (2012) Hervé Sartelet et al. HISTOPATHOLOGY
- Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells
- (2011) Annalisa Pezzolo et al. CELL RESEARCH
- Biology of Cox-2: An Application in Cancer Therapeutics
- (2011) Zakir Khan et al. CURRENT DRUG TARGETS
- PKCδ Sensitizes Neuroblastoma Cells to L-Buthionine-Sulfoximine and Etoposide Inducing Reactive Oxygen Species Overproduction and DNA Damage
- (2011) Barbara Marengo et al. PLoS One
- p38 Mitogen-Activated Protein Kinase-Driven MAPKAPK2 Regulates Invasion of Bladder Cancer by Modulation of MMP-2 and MMP-9 Activity
- (2010) B. Kumar et al. CANCER RESEARCH
- How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?
- (2010) Yohannes Mebratu et al. CELL CYCLE
- Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion
- (2010) D. Hussein et al. NEURO-ONCOLOGY
- C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells
- (2010) S. Hiratsuka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Post-Translational Regulation of Oct4 Transcriptional Activity
- (2009) Jonathan P. Saxe et al. PLoS One
- Inhibitors Targeting the LFA-1/ICAM-1 Cell-Adhesion Interaction: Design and Mechanism of Action
- (2008) Tahl Zimmerman et al. CURRENT PHARMACEUTICAL DESIGN
- Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy
- (2008) J A McCubrey et al. LEUKEMIA
- Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells
- (2008) Yu-Chih Chen et al. PLoS One
- Chemokines in neuroectodermal cancers: The crucial growth signal from the soil
- (2008) Nicole Gross et al. SEMINARS IN CANCER BIOLOGY
- Chemokines in neuroectodermal tumour progression and metastasis
- (2008) Lizzia Raffaghello et al. SEMINARS IN CANCER BIOLOGY
- Mechanisms of BSO (L-buthionine-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma
- (2007) Barbara Marengo et al. FREE RADICAL BIOLOGY AND MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search